Network Announcement: Based on IMPAACT study data, the EMA has approved Triumeq PD® for infants and children as young as 3 months of age who weigh at least 6 kg. Read the full announcement here: https://t.co/XAtfbAYb5r
Let's talk about implementation science!
Join the IMPAACT Social Behavioral Scientific Core Spotlight Series Webinar TOMORROW at 10:00 a.m. ET: https://t.co/tWbHuCFwbN
Final call - #HIVPED 2024 abstract submissions!
From Munich, Pedro invites everyone to share their recent work - welcoming research on maternal, infant, children, & adolescent #HIV prevention & care.
Submit abstracts by 26 April 👉 https://t.co/AqDLgM9wXY
#CallForAbstracts
Happy #STIAwarenessWeek! Join AVAC and @InfoASHA for two brand-new webinars this week (tomorrow, April 16 and Thursday, April 18) to discuss the current #syphillis epidemic in the US and #DoxyPEP effectiveness and AMR. Learn more and register here ✨ https://t.co/O4wEmSA1Am
Heads up: 24 March is #WorldTBDay!
The IMPAACT Network evaluates novel approaches for #TB prevention, diagnosis, and treatment in infants, children, adolescents, and pregnant and postpartum people with and without HIV.
Learn more: https://t.co/JHF72b8XHd
📢The abstract portal for the International Workshop on HIV & Pediatrics 2024 is open!
Together with Pedro, we’re thrilled to welcome submissions across nine topic categories on Pediatric #HIV research.
Explore the abstract categories & submit 👉https://t.co/3N6hfy5uS0
#HIVPED
The @IMPAACTNetwork P1115 was a complex trial. @persaud_deborah reminds us that these are very promising data, but only 6 children met the criteria and “We as a field need to do better to make better and longer-acting treatment that’s scaleable for children." cc @HopkinsKids
🆕@POTUS signed a historic Executive Order to advance research on #WomensHealth. ORWH is honored to serve alongside @NIH & various federal agencies to transform the research landscape and close gaps to improve the health of women.
More here: https://t.co/dRs71ugjZ1
Join @HIVpxresearch & @PAVE_MDC tomorrow for a webinar featuring Dr. Deborah Persaud discussing the results of IMPAACT P1115 alongside Dr. Gabriela Cromhout exploring sex differences in HIV acquisition.
🗓️21 March 2024 | 10:00-11:30 a.m. ET
REGISTER: https://t.co/ioa62cSeyE
Do you have input on #HIVresearch priorities for #NIH?
@NIH_OAR seeks input to inform the development of the next NIH strategic plan for #HIV research. Deadline - March 28. https://t.co/oS4XlK1VAQ
Scientific Committees collaborate to expand and revise research priorities and align expertise with key research areas within the network.
Apply: https://t.co/8u0CrShOM6
🚨Have you thought about getting involved? IMPAACT Scientific Committees are currently accepting applications for new members.
Apply: https://t.co/8u0CrShOM6
Today is National Women and Girls HIV/AIDS Awareness Day, a day to highlight the impact of HIV on women and girls. Visit the HIV Services Locator to find testing, treatment, and prevention or care services: https://t.co/MG7oai1jdP
#NWGHAAD
Four babies with HIV enter remission after receiving experimental drug regimen during NIH-funded study - in potential breakthrough for hundreds of kids born to infected moms each year https://t.co/nBEZfsBIVc
News coverage from #CROI2024 continues, including results from IMPAACT P1115 and IMPAACT 2017 (MOCHA). As the conference comes to a close, a comprehensive list of presentations from IMPAACT is now available: https://t.co/xnqbXnWULB